Effect of diabetes on bradykinin-induced thermal hyperalgesia in mice

European Journal of Pharmacology

Volumn 390, Issue 1-2, 2000, Pages 113-118

  Kamei, Junzo ^a   Ohsawa, Masahiro ^a   Hitosugi, Hideki ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Bradykinin; Calphostin C; Diabetes; Mouse; Phorbol 12, 13 dibutyrate; Protein kinase C; Thermal hyperalgesia

Indexed keywords

BRADYKININ; CALPHOSTIN C; ICATIBANT; PHORBOL DIBUTYRATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG ANTAGONISM; DRUG POTENTIATION; HYPERALGESIA; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; STREPTOZOCIN DIABETES; THERMAL STIMULATION;

ANIMALS; BRADYKININ; DIABETES MELLITUS, EXPERIMENTAL; ENZYME ACTIVATORS; ENZYME INHIBITORS; HEAT; HYPERALGESIA; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; NAPHTHALENES; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C; REACTION TIME;

EID: 0034712065     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00917-6     Document Type: Article

References (32)

1. Abbott F.V., Franklin K.B.J. Noncompetitive antagonism of morphine analgesia by diazepam in the formalin test. Pharmacol. Biochem. Behav. 24:1986;319-321.
2. Abbott F.V., Melzack R., Sammuel C. Morphine analgesia in the tail-flick and formalin pain tests is mediated by different neural systems. Exp. Neurol. 75:1982;644-651.
3. Allgaier C., Hertting G., Singer E.A. A detailed study on the effects of protein kinase C activation on a2-adrenoceptor-coupled modulation of norepinephrine release in hippocampus. J. Pharmacol. Exp. Ther. 258:1991;143-148.
4. Bitar M.S., Bajic K.T., Farook T., Thomas M.I., Pilcher C.W. Spinal noradrenergic dynamics in diabetic and hypercortisolaemic states. Brain Res. 830:1999;1-9.
5. Cesare P., McNaughton P. A novel heat-activated current in nociceptive neurons and its sensitization by bradykinin. Proc. Natl. Acad. Sci. U. S. A. 93:1996;15435-15439.
6. Craven P.A., De Rubertis F.R. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J. Clin. Invest. 83:1989;1667-1675.
7. Dennis S.G., Melzack R. Comparison of phasic and tonic pain in animals. Adv. Pain Res. Ther. 3:1979;747-760.
8. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
9. Hunskaar S., Berge O.G., Hole K. Dissociation between antinociceptive and anti-inflammatory effects of acetyl-salicylic acid and indomethacin in the formalin test. Pain. 25:1986;125-132.
10. Hunskaar S., Fasmer O.B., Hole K. Formalin test in mice, a useful technique for evaluating mild analgesia. J. Neurosci. Methods. 14:1985;69-76.
11. Hunskaar S., Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain. 30:1987;103-114.
12. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
13. Inoguchi T., Battan R., Handler E., Sportsman J.R., Health W., King G.L. Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc. Natl. Acad. Sci. U. S. A. 89:1992;11059-11063.
14. Kamei J., Hitosugi H., Kasuya Y. Formalin-induced nociceptive responses in diabetic mice. Neurosci. Lett. 149:1993;161-164.
15. Kamei J., Kashiwazaki T., Hitosugi H., Nagase H. Algogenic mediator-induced nociceptive response in diabetic mice. Eur. J. Pharmacol. 1999;319-323.
16. Kamei J., Ohsawa M. Role of noradrenergic functions in the modulation of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes. Life Sci. 60:1997;PL223-PL228.
17. King G.L., Johnson S., Wu G. Possible growth modulators involved in the pathogenesis of diabetic proliferative retinopathy. Westermark B., Betscholtz C., Hokfelt T. Growth Factors in Health and Diseases. 1990;303-317 Elsevier, Amsterdam.
18. Kotsonis P., Majewski H. The structural requirements for phorbol esters to enhance noradrenaline and dopamine release from rat brain cortex. Br. J. Pharmacol. 119:1996;115-125.
19. Laneuville O., Couture R. Bradykinin analogue blocks bradykinin-induced inhibition of a spinal nociceptive reflex in the rat. Eur. J. Pharmacol. 137:1987;281-285.
20. Laneuville O., Reader T.A., Couture R. Intrathecal bradykinin acts presynaptically on spinal noradrenergic terminals to produce antinociception in the rat. Eur. J. Pharmacol. 15:1989;273-283.
21. Mizumura K., Koda H., Kumazawa T. Evidence that protein kinase C activation is involved in the excitatory and facilitatory effects of bradykinin on canine visceral nociceptors in vitro. Neurosci. Lett. 14:1997;29-32.
22. Murray C.W., Porreca F., Cowan A. Methodological refinements to the mouse paw formalin test. J. Pharmacol. Methods. 20:1988;175-186.
23. Narita M., Ohsawa M., Mizoguchi H., Kamei J., Tseng L.F. Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by μ-but not ε-opioid receptor agonist in the mouse. Neuroscience. 76:1997;291-298.
24. Ohkubo T., Shibata M., Takahashi H., Inoki R. Roles of substance P and somatostatin on transmission of nociceptive information induced by formalin in spinal cord. J. Pharmacol. Exp. Ther. 252:1990;1261-1268.
25. Ohsawa M., Kamei J. Possible involvement of protein kinase C in the attenuation of DAMGO-induced antinociception in diabetic mice. Eur. J. Pharmacol. 339:1997;27-31.
26. Ohsawa M., Kamei J. Possible involvement of spinal protein kinase C in the thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol. 372:1999;221-228.
27. Ohsawa M., Kashiwazaki T., Kamei J. Modulation of the formalin-induced nociceptive response by diabetes: possible involvement of protein kinase C. Brain Res. 803:1998;198-203.
28. Schroeder G.E., Kotsonis P., Musgrave I.F., Majewski H. Protein kinase C involvement in maintenance and modulation of noradrenaline release in the mouse brain cortex. Br. J. Pharmacol. 116:1995;2757-2763.
29. Shibata M., Ohkubo T., Takahashi H., Inoki R. Modified formalin test: characteristic biphasic pain response. Pain. 38:1989;347-352.
30. Tanaka A., Kashiwagi Y., Ogawa T., Abe N., Asahina T., Ikebuchi M., Takagi Y., Shigeta Y. Effect of verapamil on cardiac protein kinase C activity in diabetic rats. Eur. J. Pharmacol. 200:1991;353-356.
31. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the methods. Pain. 51:1992;5-17.
32. 3H]norepinephrine from rat cortical slices. J. Pharmacol. Exp. Ther. 285:1998;105-109.